< Insights

Two Posters in Multiple Sclerosis

The results of a quantitative survey of over 1,100 members of MyMSTeam and the analysis of organic conversations of over 3,300 members revealed patient priorities and perceptions of DMT’s in multiple sclerosis. These two posters were presented at the Consortium of Multiple Sclerosis Centers annual meeting in New Orleans, 2017.

For questions about this research or to discuss partnering on future research, please email us.

MyMSTeam and Disease Modifying Treatments (DMTs)